Literature DB >> 10090190

Conceptual issues in scoring radiographic progression in rheumatoid arthritis.

J R Kirwan1.   

Abstract

Radiographic scoring systems for rheumatoid arthritis (RA) should be based on current understanding of disease pathology. Evidence suggests that there may be at least two intraarticular pathologies that may result in change in different radiographic features. There is therefore a strong argument for devising a radiographic score based on the observation of features rather than broad categorizations of the total radiographic change. Features may subsequently be amalgamated in relation to other criteria such as sensitivity, specificity, and responsiveness to change, and may be related to subsequent developments in understanding the biology of RA. A second challenge is in elucidating the relationship between radiographic change and the longterm consequences of RA for the patient. Current practice is predicated on the assumption that in the longterm radiographic change correlates well with functional loss and possibly noninflammatory, endstage joint pain. Although hand and feet radiographs broadly represent destructive change in all joints, in cross sectional studies they correlate only moderately with late stage functional loss. The issue may be resolved by longterm observational studies of radiographic change and functional loss. It is recommended that specific radiographic features relevant to joint pathophysiology be used to create a radiographic damage index for comparison with current scoring systems and that longterm observational studies specifically address the relationship between radiographic joint damage and functional outcome.

Entities:  

Mesh:

Year:  1999        PMID: 10090190

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

1.  Association between baseline radiographic damage and improvement in physical function after treatment of patients with rheumatoid arthritis.

Authors:  F C Breedveld; C Han; M Bala; D van der Heijde; D Baker; A F Kavanaugh; R N Maini; P E Lipsky
Journal:  Ann Rheum Dis       Date:  2004-07-29       Impact factor: 19.103

2.  The CD44v7/8 epitope as a target to restrain proliferation of fibroblast-like synoviocytes in rheumatoid arthritis.

Authors:  A Wibulswas; D Croft; I Bacarese-Hamilton; P McIntyre; E Genot; I M Kramer
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

3.  Carpal collapse in patients with rheumatoid arthritis.

Authors:  Halil Uçan; Pinar Borman; Dilek Keskin; Nurdan Barça
Journal:  Clin Rheumatol       Date:  2006-01-21       Impact factor: 2.980

Review 4.  Prevention or retardation of joint damage in rheumatoid arthritis: issues of definition, evaluation and interpretation of plain radiographs.

Authors:  Maarten Boers; Désirée M F M van der Heijde
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 5.  Pursuit of optimal outcomes in rheumatoid arthritis.

Authors:  David L Scott
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

6.  Trends towards an improved disease state in rheumatoid arthritis over time: influence of new therapies and changes in management approach: analysis of the EMECAR cohort.

Authors:  Isidoro González-Alvaro; Miguel Angel Descalzo; Loreto Carmona
Journal:  Arthritis Res Ther       Date:  2008-11-26       Impact factor: 5.156

7.  Correlation of the score for subjective pain with physical disability, clinical and radiographic scores in recent onset rheumatoid arthritis.

Authors:  Piercarlo Sarzi-Puttini; Tania Fiorini; Benedetta Panni; Maurizio Turiel; Marco Cazzola; Fabiola Atzeni
Journal:  BMC Musculoskelet Disord       Date:  2002-07-19       Impact factor: 2.362

8.  Efficacy of early immunomodulator therapy on the outcomes of Crohn's disease.

Authors:  Min Seob Kwak; Duk Hwan Kim; Soo Jung Park; Tae Il Kim; Sung Pil Hong; Won Ho Kim; Jae Hee Cheon
Journal:  BMC Gastroenterol       Date:  2014-05-03       Impact factor: 3.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.